Gilead Sciences
GILD
#129
Rank
C$207.79 B
Marketcap
C$167.47
Share price
-1.14%
Change (1 day)
30.79%
Change (1 year)

Revenue for Gilead Sciences (GILD)

Revenue in 2025 (TTM): C$40.90 Billion

According to Gilead Sciences's latest financial reports the company's current revenue (TTM ) is C$40.18 Billion. In 2024 the company made a revenue of C$41.25 Billion an increase over the revenue in the year 2023 that were of C$35.96 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gilead Sciences from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$40.90 B-0.86%
2024 C$41.25 B14.73%
2023 C$35.96 B-2.85%
2022 C$37.01 B6.38%
2021 C$34.79 B10.54%
2020 C$31.48 B7.37%
2019 C$29.31 B-2.73%
2018 C$30.14 B-8.17%
2017 C$32.82 B-19.63%
2016 C$40.83 B-9.8%
2015 C$45.27 B56.75%
2014 C$28.88 B142.24%
2013 C$11.92 B23.59%
2012 C$9.64 B13.11%
2011 C$8.52 B7.34%
2010 C$7.94 B7.71%
2009 C$7.37 B13.71%
2008 C$6.48 B53.74%
2007 C$4.21 B19.77%
2006 C$3.52 B49.19%
2005 C$2.36 B48.43%
2004 C$1.59 B41.32%
2003 C$1.12 B52.7%
2002 C$0.73 B97.97%
2001 C$0.37 B25.42%
2000 C$0.29 B21.81%
1999 C$0.24 B157.8%
1998 C$94.55 M65.45%
1997 C$57.15 M24.56%
1996 C$45.88 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
C$49.69 B 23.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$16.19 B-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$82.39 B 105.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$5.92 B-85.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.90 B-65.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 115.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$127.30 B 216.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$82.08 B 104.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$88.74 B 120.85%๐Ÿ‡บ๐Ÿ‡ธ USA